<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">22532442</PMID>
      <DateCompleted>
        <Year>2012</Year>
        <Month>10</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1530-6860</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <Issue>8</Issue>
            <PubDate>
              <Year>2012</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</Title>
          <ISOAbbreviation>FASEB J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Signaling through the neuropeptide GPCR PAC₁ induces neuritogenesis via a single linear cAMP- and ERK-dependent pathway using a novel cAMP sensor.</ArticleTitle>
        <Pagination>
          <StartPage>3199</StartPage>
          <EndPage>3211</EndPage>
          <MedlinePgn>3199-211</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1096/fj.11-203042</ELocationID>
        <Abstract>
          <AbstractText>Both cAMP and ERK are necessary for neuroendocrine cell neuritogenesis, and pituitary adenylate cyclase-activating polypeptide (PACAP) activates each. It is important to know whether cAMP and ERK are arranged in a novel, linear pathway or in two parallel pathways using known signaling mechanisms. Native cellular responses [cAMP elevation, ERK phosphorylation, cAMP responsive element binding (CREB) phosphorylation, and neuritogenesis] and promoter-reporter gene activation after treatment with forskolin, cAMP analogs, and PACAP were measured in Neuroscreen-1 (NS-1) cells, a PC12 variant enabling simultaneous morphological, molecular biological, and biochemical analysis. Forskolin (25 μM) and cAMP analogs (8-bromo-cAMP, dibutyryl-cAMP, and 8-chlorophenylthio-cAMP) stimulated ERK phosphorylation and neuritogenesis in NS-1 cells. Both ERK phosphorylation and neuritogenesis were MEK dependent (blocked by 10 μM U0126) and PKA independent (insensitive to 30 μM H-89 or 100 nM myristoylated protein kinase A inhibitor). CREB phosphorylation induced by PACAP was blocked by H-89. The exchange protein activated by cAMP (Epac)-selective 8-(4-chlorophenylthio)-2'-O-Me-cAMP (100-500 μM) activated Rap1 without affecting the other cAMP-dependent processes. Thus, PACAP-38 potently stimulated two distinct and independent cAMP pathways leading to CREB or ERK activation in NS-1 cells. Drug concentrations for appropriate effect were derived from control data for all compounds. In summary, a novel PKA- and Epac-independent signaling pathway: PACAP → adenylate cyclase → cAMP → ERK → neuritogenesis has been identified.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Emery</LastName>
            <ForeName>Andrew C</ForeName>
            <Initials>AC</Initials>
            <AffiliationInfo>
              <Affiliation>Section on Molecular Neuroscience, Laboratory of Cellular and Molecular Regulation, National Institute of Mental Health, Bethesda, Maryland 20892-4090, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Eiden</LastName>
            <ForeName>Lee E</ForeName>
            <Initials>LE</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>Z01 MH002386</GrantID>
            <Agency>Intramural NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>1-Z01-MH002386</GrantID>
            <Acronym>MH</Acronym>
            <Agency>NIMH NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2012</Year>
          <Month>04</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>FASEB J</MedlineTA>
        <NlmUniqueID>8804484</NlmUniqueID>
        <ISSNLinking>0892-6638</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051219">Pituitary Adenylate Cyclase-Activating Polypeptide</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>1F7A44V6OU</RegistryNumber>
          <NameOfSubstance UI="D005576">Colforsin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>E0399OZS9N</RegistryNumber>
          <NameOfSubstance UI="D000242">Cyclic AMP</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.11</RegistryNumber>
          <NameOfSubstance UI="D017868">Cyclic AMP-Dependent Protein Kinases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.24</RegistryNumber>
          <NameOfSubstance UI="D048049">Extracellular Signal-Regulated MAP Kinases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 4.6.1.1</RegistryNumber>
          <NameOfSubstance UI="D000262">Adenylyl Cyclases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000262" MajorTopicYN="N">Adenylyl Cyclases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005576" MajorTopicYN="N">Colforsin</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000242" MajorTopicYN="N">Cyclic AMP</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017868" MajorTopicYN="N">Cyclic AMP-Dependent Protein Kinases</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D048049" MajorTopicYN="N">Extracellular Signal-Regulated MAP Kinases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016501" MajorTopicYN="N">Neurites</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016716" MajorTopicYN="N">PC12 Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051219" MajorTopicYN="N">Pituitary Adenylate Cyclase-Activating Polypeptide</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2012</Year>
          <Month>4</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2012</Year>
          <Month>4</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2012</Year>
          <Month>10</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">22532442</ArticleId>
        <ArticleId IdType="pmc">PMC3405272</ArticleId>
        <ArticleId IdType="doi">10.1096/fj.11-203042</ArticleId>
        <ArticleId IdType="pii">fj.11-203042</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Greengard P. (2001) The neurobiology of slow synaptic transmission. Science
294, 1024–1030</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11691979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kandel E. R. (2001) The molecular biology of memory storage: a dialogue between genes and synapses. Science
294, 1030–1038</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11691980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bers D. M. (2007) Going to cAMP just got more complicated. J. Physiol.
583, 415–416</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2277018</ArticleId>
            <ArticleId IdType="pubmed">17656427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hamelink C., Lee H.-W., Grimaldi M., Eiden L. E. (2002) Coincident elevation of cyclic AMP and calcium influx by PACAP-27 synergistically regulates VIP gene transcription through a novel PKA-independent signaling pathway. J. Neurosci.
22, 5310–5320</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6758207</ArticleId>
            <ArticleId IdType="pubmed">12097482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ravni A., Vaudry D., Gerdin M. J., Eiden M. V., Falluel-Morel A., Gonzalez B., Vaudry H., Eiden L. E. (2008) A cAMP-dependent, PKA-independent signaling pathway mediating neuritogenesis through Egr1 in PC12 cells. Mol. Pharmacol.
73, 1688–1708</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4188547</ArticleId>
            <ArticleId IdType="pubmed">18362103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Holighaus Y., Weihe E., Eiden L. E. (2012) STC1 induction by PACAP is mediated through cAMP and ERK1/2 but not PKA in cultured cortical neurons. J. Mol. Neurosci.
46, 75–87</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3256285</ArticleId>
            <ArticleId IdType="pubmed">21975601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kim H. S., Yumkham S., Kim S. H., Yea K., Shin Y. C., Ryu S. H., Suh P. G. (2006) Secretin induces neurite outgrowth of PC12 through cAMP-mitogen-activated protein kinase pathway. Exp. Mol. Med.
38, 85–93</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16520556</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cibelli G., Corsi P., Diana G., Vitiello F., Thiel G. (2001) Corticotropin-releasing factor triggers neurite outgrowth of a catecholaminergic immortalized neuron via cAMP and MAP kinase signalling pathways. Eur. J. Neurosci.
13, 1339–1348</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11298794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Monaghan T. K., Mackenzie C. J., Plevin R., Lutz E. M. (2008) PACAP-38 induces neuronal differentiation of human SH-SY5Y neuroblastoma cells via cAMP-mediated activation of ERK and p38 MAP kinases. J. Neurochem.
104, 74–88</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2230095</ArticleId>
            <ArticleId IdType="pubmed">17995938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gerdin M. J., Eiden L. E. (2007) Regulation of PC12 cell differentiation by cAMP signaling to ERK independent of PKA: do all the connections add up?
Sci. STKE
2007, pe15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4183209</ArticleId>
            <ArticleId IdType="pubmed">17440132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Obara Y., Labudda K., Dillon T. J., Stork P. J. (2004) PKA phosphorylation of Src mediates Rap1 activation in NGF and cAMP signaling in PC12 cells. J. Cell Sci.
117, 6085–6094</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15546918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
York R. D., Yao H., Dillon T., Ellig C. L., Eckert S. P., McCleskey E. W., Stork P. J. S. (1998) Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature
392, 622–626</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9560161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Vaudry D., Chen Y., Ravni A., Hamelink C., Elkahloun A. G., Eiden L. E. (2002) Analysis of the PC12 cell transcriptome after differentiation with pituitary adenylate cyclase-activating polypeptide (PACAP). J. Neurochem.
83, 1272–1284</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4186721</ArticleId>
            <ArticleId IdType="pubmed">12472882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lazarovici P., Jiang H., Fink D., Jr. (1998) The 38-amino-acid form of pituitary adenylate cyclase-activating polypeptide induces neurite outgrowth in PC12 cells that is dependent on protein kinase C and extracellular signal-regulated kinase but not on protein kinase A, nerve growth factor receptor tyrosine kinase, p21ras G protein, and pp60c-src cytoplasmic tyrosine kinase. Mol. Pharmacol.
54, 547–558</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9730914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ginty D. D., Glowacka D., DeFranco C., Wagner J. A. (1991) Nerve growth factor-induced neuronal differentiation after dominant repression of both type I and type II cAMP-dependent protein kinase activities. J. Biol. Chem.
266, 15325–15333</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1651325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Stork P. J., Schmitt J. M. (2002) Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol.
12, 258–266</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12074885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Enserink J. M., Christensen A. E., de Rooij J., van Triest M., Schwede F., Genieser H. G., Doskeland S. O., Blank J. L., Bos J. L. (2002) A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat. Cell Biol.
4, 901–906</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12402047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang Z., Dillon T. J., Pokala V., Mishra S., Labudda K., Hunter B., Stork P. J. (2006) Rap1-mediated activation of extracellular signal-regulated kinases by cyclic AMP is dependent on the mode of Rap1 activation. Mol. Cell. Biol.
26, 2130–2145</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1430276</ArticleId>
            <ArticleId IdType="pubmed">16507992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gutkind J. S. (2000) Regulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors. Sci. STKE
2000, re1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11752597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Radio N. M., Breier J. M., Shafer T. J., Mundy W. R. (2008) Assessment of chemical effects on neurite outgrowth in PC12 cells using high content screening. Toxicol. Sci.
105, 106–118</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18539913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Deutsch P. J., Sun Y. (1992) The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth. J. Biol. Chem.
267, 5108–5113</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1312085</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Grumolato L., Louiset E., Alexandre D., Ait-Ali D., Turquier V., Fournier A., Fasolo A., Vaudry H., Anouar Y. (2003) PACAP and NGF regulate common and distinct traits of the sympathoadrenal lineage: effects on electrical properties, gene markers and transcription factors in differentiating PC12 cells. Eur. J. Neurosci.
17, 71–82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12534970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Samal B. B., Eiden L. E. (2008) pathFinder: a static network analysis tool for pharmacological analysis of signal transduction pathways. Sci. Signal.
1, pt4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2719891</ArticleId>
            <ArticleId IdType="pubmed">18682604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ueda Y., Hirai S., Osada S., Suzuki A., Mizuno K., Ohno S. (1996) Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J. Biol. Chem.
271, 23512–23519</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8798560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Dumaz N., Marais R. (2005) Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft fur Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in Brussels. FEBS J.
272, 3491–3504</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16008550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lioudyno M., Skoglosa Y., Takei N., Lindholm D. (1998) Pituitary adenylate cyclase-activating polypeptide (PACAP) protects dorsal root ganglion neurons from death and induces calcitonin gene-related peptide (CGRP) immunoreactivity in vitro. J. Neurosci. Res.
51, 243–256</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9469578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Guirland C., Buck K. B., Gibney J. A., DiCicco-Bloom E., Zheng J. Q. (2003) Direct cAMP signaling through G-protein-coupled receptors mediates growth cone attraction induced by pituitary adenylate cyclase-activating polypeptide. J. Neurosci.
23, 2274–2283</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6742047</ArticleId>
            <ArticleId IdType="pubmed">12657686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Armstrong B. D., Abad C., Chhith S., Cheung-Lau G., Hajji O. E., Nobuta H., Waschek J. A. (2008) Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide. Neuroscience
151, 63–73</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2245872</ArticleId>
            <ArticleId IdType="pubmed">18055122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Waschek J. A., Dicicco-Bloom E., Nicot A., Lelievre V. (2006) Hedgehog signaling: new targets for GPCRs coupled to cAMP and protein kinase A. Ann. N. Y. Acad. Sci.
1070, 120–128</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16888153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tan Y. V., Abad C., Lopez R., Dong H., Liu S., Lee A., Gomariz R. P., Leceta J., Waschek J. A. (2009) Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U. S. A.
106, 2012–2017</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2644155</ArticleId>
            <ArticleId IdType="pubmed">19190179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Voice J. K., Grinninger C., Kong Y., Bangale Y., Paul S., Goetzl E. J. (2003) Roles of vasoactive intestinal peptide (VIP) in the expression of different immune phenotypes by wild-type mice and T cell-targeted type II VIP receptor transgenic mice. J. Immunol.
170, 308–314</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12496414</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Abad C., Martinez C., Leceta J., Gomariz R. P., Delgado M. (2001) Pituitary adenylate cyclase-activating polypeptide inhibits collagen-induced arthritis: an experimental immunomodulatory therapy. J. Immunol.
167, 3182–3189</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11544304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gressens P., Hill J. M., Gozes I., Fridkin M., Brenneman D. E. (1993) Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature
362, 155–158</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8383805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Vaudry D., Gonzalez B. J., Basille M., Fournier A., Vaudry H. (1999) Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development. Proc. Natl. Acad. Sci. U. S. A.
96, 9415–9420</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC17797</ArticleId>
            <ArticleId IdType="pubmed">10430957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
DiCicco-Bloom E., Deutsch P. J., Maltzman J., Zhang J., Pintar J. E., Zheng J., Friedman W. F., Zhou X., Zaremba T. (2000) Autocrine expression and ontogenetic functions of the PACAP ligand/receptor system during sympathetic development. Dev. Biol.
219, 197–213</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10694416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Otto C., Kovalchuk Y., Wolfer D. P., Gass P., Martin M., Zuschratter W., Gröne H. J., Kellendonk C., Tronche F., Maldonado R., Lipp H.-P., Konnerth A., Schütz G. (2001) Impairment of mossy fiber long-term potentiation and associative learning in pituitary adenylate cyclase activating polypeptide type I receptor-deficient mice. J. Neurosci.
21, 5520–5527</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6762677</ArticleId>
            <ArticleId IdType="pubmed">11466423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Macdonald D. S., Weerapura M., Beazely M. A., Martin L., Czerwinski W., Roder J. C., Orser B. A., MacDonald J. F. (2005) Modulation of NMDA receptors by pituitary adenylate cyclase activating peptide in CA1 neurons requires Gαq, protein kinase C, and activation of Src. J. Neurosci.
25, 11374–11384</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6725893</ArticleId>
            <ArticleId IdType="pubmed">16339032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ohtaki H., Nakamachi T., Dohi K., Shioda S. (2008) Role of PACAP in ischemic neural death. J. Mol. Neurosci.
36, 16–25</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18483879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chen Y., Samal B., Hamelink C. R., Xiang C. C., Chen Y., Chen M., Vaudry D., Brownstein M. J., Hallenbeck J. M., Eiden L. E. (2006) Neuroprotection by endogenous and exogenous PACAP following stroke. Regul. Pept.
137, 4–19</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4183206</ArticleId>
            <ArticleId IdType="pubmed">17027094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ohtaki H., Nakamachi T., Dohi K., Aizawa Y., Takaki A., Hodoyama K., Yofu S., Hashimoto H., Shintani N., Baba A., Kopf M., Iwakura Y., Matsuda K., Arimura A., Shioda S. (2006) Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6. Proc. Natl. Acad. Sci. U. S. A.
103, 7488–7493</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1464366</ArticleId>
            <ArticleId IdType="pubmed">16651528</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Grumolato L., Elkahloun A. G., Ghzili H., Alexandre D., Coulouarn C., Yon L., Salier J. P., Eiden L. E., Fournier A., Vaudry H., Anouar Y. (2003) Microarray and suppression subtractive hybridization analyses of gene expression in pheochromocytoma cells reveal pleiotropic effects of pituitary adenylate cyclase-activating polypeptide on cell proliferation, survival, and adhesion. Endocrinology
144, 2368–2379</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12746297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hammack S. E., Cheung J., Rhodes K. M., Schutz K. C., Falls W. A., Braas K. M., May V. (2009) Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior. Psychoneuroendocrinology
34, 833–843</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2705919</ArticleId>
            <ArticleId IdType="pubmed">19181454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Stroth N., Liu Y., Aguilera G., Eiden L. E. (2011) Pituitary adenylate cyclase-activating polypeptide (PACAP) controls stimulus-transcription coupling in the hypothalamic-pituitary-adrenal axis to mediate sustained hormone secretion during stress. J. Neuroendocrinol.
23, 944–955</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3183119</ArticleId>
            <ArticleId IdType="pubmed">21824204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hashimoto H., Shintani N., Tanaka K., Mori W., Hirose M., Matsuda T., Sakaue M., Miyazaki J.-I., Niwa H., Tashiro F., Yamamoto K., Koga K., Tomimoto S., Kunugi A., Suetake S., Baba A. (2001) Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc. Natl. Acad. Sci. U. S. A.
98, 13355–13360</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC60875</ArticleId>
            <ArticleId IdType="pubmed">11687615</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chen D., Buchanan G. F., Ding J. M., Hannibal J., Gillette M. U. (1999) Pituitary adenylyl cyclase-activating peptide: a pivotal modulator of glutamatergic regulation of the suprachiasmatic circadian clock. Proc. Natl. Acad. Sci. U. S. A.
96, 13468–13473</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC23971</ArticleId>
            <ArticleId IdType="pubmed">10557344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lelievre V., Seksenyan A., Nobuta H., Yong W. H., Chhith S., Niewiadomski P., Cohen J. R., Dong H., Flores A., Liau L. M., Kornblum H. I., Scott M. P., Waschek J. A. (2008) Disruption of the PACAP gene promotes medulloblastoma in ptc1 mutant mice. Dev. Biol.
313, 359–370</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2206628</ArticleId>
            <ArticleId IdType="pubmed">18036580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Vaudry D., Gonzalez B. J., Basille M., Anouar Y., Fournier A., Vaudry H. (1998) Pituitary adenylate cyclase-activating polypeptide stimulates both c-Fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway. Neuroscience
84, 801–812</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9579785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Vaudry D., Falluel-Morel A., Basille M., Pamantung T. F., Fontaine M., Fournier A., Vaudry H., Gonzalez B. J. (2003) Pituitary adenylate cyclase-activating polypeptide prevents C2-ceramide-induced apoptosis of cerebellar granule cells. J. Neurosci. Res.
72, 303–316</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12692897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ster J., De Bock F., Guerineau N. C., Janossy A., Barrere-Lemaire S., Bos J. L., Bockaert J., Fagni L. (2007) Exchange protein activated by cAMP (Epac) mediates cAMP activation of p38 MAPK and modulation of Ca2+-dependent K+ channels in cerebellar neurons. Proc. Natl. Acad. Sci. U. S. A.
104, 2519–2524</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1892910</ArticleId>
            <ArticleId IdType="pubmed">17284589</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Roscioni S. S., Kistemaker L. E., Menzen M. H., Elzinga C. R., Gosens R., Halayko A. J., Meurs H., Schmidt M. (2009) PKA and Epac cooperate to augment bradykinin-induced interleukin-8 release from human airway smooth muscle cells. Respir. Res.
10, 88.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2764632</ArticleId>
            <ArticleId IdType="pubmed">19788733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Nijholt I. M., Dolga A. M., Ostroveanu A., Luiten P. G., Schmidt M., Eisel U. L. (2008) Neuronal AKAP150 coordinates PKA and Epac-mediated PKB/Akt phosphorylation. Cell. Signal.
20, 1715–1724</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18565730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pham N., Cheglakov I., Koch C. A., de Hoog C. L., Moran M. F., Rotin D. (2000) The guanine nucleotide exchange factor CNrasGEF activates ras in response to cAMP and cGMP. Curr. Biol.
10, 555–558</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10801446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sun H., Charles C. H., Lau L. F., Tonks N. K. (1993) MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell
75, 487–493</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8221888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Burgun C., Esteve L., Humblot N., Aunis D., Zwiller J. (2000) Cyclic AMP-elevating agents induce the expression of MAP kinase phosphatase-1 in PC12 cells. FEBS Lett.
484, 189–193</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11078876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Engh R. A., Girod A., Kinzel V., Huber R., Bossemeyer D. (1996) Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity. J. Biol. Chem.
271, 26157–26164</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8824261</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cheadle C., Nesterova M., Watkins T., Barnes K. C., Hall J. C., Rosen A., Becker K. G., Cho-Chung Y. S. (2008) Regulatory subunits of PKA define an axis of cellular proliferation/differentiation in ovarian cancer cells. BMC Med. Genomics
1, 43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2577111</ArticleId>
            <ArticleId IdType="pubmed">18822129</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
